Pacira BioSciences, Inc. (PCRX) Stock Overview
Explore Pacira BioSciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Pacira BioSciences, Inc. (PCRX)
Key Financials
Key Financials
Market Cap
894.9M
P/E Ratio
178.84
EPS (TTM)
$0.13
ROE
0.01%
PCRX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Pacira BioSciences, Inc. (PCRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 44.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $25.27.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 178.84 and a market capitalization of 894.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.